Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
Herein, we report the effect of nine FDA approved protease inhibitor drugs against a new HIV-1 subtype C mutant protease, E35D↑G↑S. The mutant has five mutations, E35D, two insertions, position 36 (G and S), and D60E. Kinetics, inhibition constants, vitality, Gibbs free binding energies are reported...
Saved in:
Main Authors: | Sibusiso Maseko (Author), Eden Padayachee (Author), Siyabonga Maphumulo (Author), Thavendran Govender (Author), Yasien Sayed (Author), Glenn Maguire (Author), Johnson Lin (Author), Tricia Naicker (Author), Sooraj Baijnath (Author), Kruger Hendrik Gerhardus (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008) -
PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2010) -
PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2010) -
High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication
by: Sonald Duclair, et al.
Published: (2015) -
Longitudinal study of HIV protease mutations in oral tissues of selected patients
by: Peter J. Hickman, et al.
Published: (2015)